Meeting of the BRICS Working Group on Nuclear Medicine

February, 13

14:00–15:30

Biotechnologies in Personalized Healthcare, Including Active Longevity and Preventive Medicine Technologies

World Trade Center Moscow, entrance No. 4, 1st floor, conference hall 1. ROSATOM

New cancer cases and high mortality and disability rates are being reported among able-bodied people worldwide with increasing frequency even as the demand for modern nuclear medicine in national healthcare systems grows. Nuclear medicine is being applied clinically across fields, with radionuclide diagnostics becoming routine in the detection of malignant neoplasms and in cardiology and neurology among others. Modern therapeutic methods employing radioisotopes in medicine (targeted alpha therapy, theranostics) are increasingly common in the treatment of various types of cancer. There is significant potential in BRICS for the development and application of nuclear medicine for the diagnosis and treatment of oncological and non-oncological diseases alike. In July 2023, more than 200 representatives from BRICS members Brazil, Russia, India, China, and South Africa participated in the International BRICS Expert Forum on Nuclear Medicine in Moscow and Obninsk. The result was a consolidation of recommendations and proposals from the professional expert community for the development of nuclear medicine and radiopharmaceuticals in BRICS. The initiative was endorsed during the BRICS Health Ministers’ Meeting held in August 2023, and it was recommended that a working group be established to explore the initiatives and other possible projects. The establishment of the working group was welcomed during the BRICS Summit, and all nations were encouraged to join in the task. The group’s first meeting is scheduled to take place soon and will look to discuss and confirm the structure of the group and plans for 2024 and review its first initiatives in nuclear medicine. Overviews will also be presented on the outlook for nuclear medicine in new BRICS members showing an interest in consolidating efforts and working together.

Moderators:

First Deputy General Director, Director of the Development and International Business Unit, State Atomic Energy Corporation ROSATOM

Deputy Director for Research, Academician A.M. Granova Scientific Center of Radiology and Surgical Technologies of the Ministry of Health of the Russian Federation

Panellists:

(online)

Professor of Nuclear Medicine, Tehran University of Medical Sciences; Director of the Nuclear Medicine Department, Khomeini Hospital

Head of the Clinical Nuclear Medicine Department, St. Paul's Hospital Millennium Medical College

Deputy Minister of Health of the Russian Federation

Head of Nuclear Medicine Department, Netcare Umhlanga and Hibiscus Hospitals; Secretary, World Association of Radiopharmaceutical and Molecular Therapy (WARMTH)

Professor, Indian Institute of Technology Roorkee

Director of PET/CT and Theranostics Unit, Misr Radiology Center

Head of Scientific and Clinical Association of Nuclear Medicine, Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation

Front row participants:

(online)

Chief Technology Officer, China Isotope and Radiation Corporation (CIRC)

(online)

President, Brazilian Society of Nuclear Medicine and Molecular Imaging; Director of the Department of Radionuclide Diagnostics and Therapy, Hospital do Coração

(online)

General Manager, NTP Radioisotopes SOC Ltd.

(online)

President, Society of Nuclear Medicine India

трансляция